Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS (Parenthetical)

v3.24.1.1.u2
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Cash and cash equivalents $ 545,084 $ 581,417 $ 225,464
Restricted cash 462,637 445,528  
Trading securities 3,688,620 2,412,556 1,158,377
Margin lending, brokerage and other receivables, net 1,660,275 376,329 147,659
Loans issued 1,381,715 826,258  
Other assets, net 102,414 73,463  
Customer liabilities 2,273,830 1,925,247 765,628
Margin lending and trade payables 867,880 122,900 45,083
Liabilities from insurance activity 297,180 182,502 $ 122,087
Other liabilities $ 81,560 $ 30,060  
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001 $ 0.001
Preferred stock, authorized (in shares) 20,000,000 20,000,000 20,000,000
Preferred stock, issued (in shares) 0 0 0
Preferred stock, outstanding (in shares) 0 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001 $ 0.001
Common stock, authorized (in shares) 500,000,000 500,000,000 500,000,000
Common stock, issued (in shares) 60,321,813 59,659,191 59,542,212
Common stock, outstanding (in shares) 60,321,813 59,659,191 59,542,212
Related party      
Cash and cash equivalents $ 203 $ 35,549  
Restricted cash 0 114,885  
Trading securities 1,326 556  
Margin lending, brokerage and other receivables, net 22,039 295,611  
Loans issued 147,440 121,316  
Other assets, net 5,257 16,102  
Customer liabilities 44,127 130,210  
Margin lending and trade payables 507 3,721  
Liabilities from insurance activity 470 34  
Other liabilities $ 9,854 $ 46